Amgen files quarterly report (10-Q) for the period ended Jun 30, 2026

Amgen filed its quarterly report on Form 10-Q with the SEC on Aug 4, 2026, 6:29 PM ET, covering the quarter ended Jun 30, 2026. It reports fiscal Q2 2026 results.

• Revenue: $10.05B (+9.5% from $9.18B a year earlier)
• Operating income: $3.51B (+32.3% from $2.66B a year earlier)
• Net income: $2.38B (+65.9% from $1.43B a year earlier)
• Diluted EPS: $4.37 (+64.9% from $2.65 a year earlier)
• Form 10-Q accepted by EDGAR Aug 4, 2026, 6:29 PM ET
• Accession number 0000318154-26-000126

SEC filing 10-Q · accession 0000318154-26-000126 · sec.gov ↗